SCHEMBL5865112

SCHEMBL5865112

[O-][n+]1ccccc1/C=C/c1ccc(Cl)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.55
MEN1 O00255 1/20 0.55
NPC1 O15118 1/20 0.55
KMT2A Q03164 1/20 0.55
CHAT P28329 3/20 0.53
KDM4A O75164 1/20 0.41
KDM4B O94953 1/20 0.41
PABPC1 P11940 1/20 0.40
EIF4H Q15056 1/20 0.40
ALDH1A1 P00352 2/20 0.39
APOBEC3A P31941 2/20 0.36
APOBEC3G Q9HC16 2/20 0.36
PYGL P06737 3/20 0.36
MAOB P27338 2/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
GLA P06280 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PTGS2 P35354 1/20 0.35
ABCG2 Q9UNQ0 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5865117 1.00 RAB9A (0.55) RAB9AMEN1NPC1KMT2ACHAT
SCHEMBL5864841 0.81 RAB9A (0.64) RAB9AMEN1NPC1KMT2ACHAT
SCHEMBL5864837 0.81 RAB9A (0.64) RAB9AMEN1NPC1KMT2ACHAT
SCHEMBL5865244 0.81 CHAT (0.57) RAB9AMEN1NPC1KMT2ACHAT
SCHEMBL5865241 0.81 CHAT (0.57) RAB9AMEN1NPC1KMT2ACHAT
SCHEMBL4712805 0.77 RAB9A (0.67) RAB9AMEN1NPC1KMT2ACHAT
SCHEMBL4712807 0.77 RAB9A (0.67) RAB9AMEN1NPC1KMT2ACHAT
SCHEMBL5865005 0.75 RAB9A (0.64) RAB9AMEN1NPC1KMT2APABPC1
SCHEMBL5865373 0.75 RAB9A (0.69) RAB9AMEN1NPC1KMT2ACHAT
SCHEMBL5865378 0.75 RAB9A (0.69) RAB9AMEN1NPC1KMT2ACHAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
US-6951875-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed
EP-1443926-A1 PYRIDINE DERIVATIVES AS NMDA-RECEPTOR SUBTYPE BLOCKERS F. HOFFMANN-LA ROCHE AG (CH) 2004-08-11 EP disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. 2003-07-31 US disclosed
WO-2003037333-A1 PYRIDINE DERIVATIVES AS NMDA-RECEPTOR SUBTYPE BLOCKERS F. HOFFMANN-LA ROCHE AG (CH) 2003-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C RAB9A 2741/4885MEN1 2517/4885NPC1 646/4885
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C RAB9A 2741/4885MEN1 2517/4885NPC1 646/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C RAB9A 2959/4885MEN1 2586/4885NPC1 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.